Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo

por Starenki, Dmytro, Park, Jong-In
Publicado 2015

Pediatric Medullary Thyroid Carcinoma

por Starenki, Dmytro, Park, Jong-In
Publicado 2015

The Role of STAT3 in Thyroid Cancer

por Sosonkina, Nadiya, Starenki, Dmytro, Park, Jong-In
Publicado 2014

Autophagy sensitivity of neuroendocrine lung tumor cells

por HONG, SEUNG-KEUN, KIM, JIN-HWAN, STARENKI, DMYTRO, PARK, JONG-IN
Publicado 2013

Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells

por Starenki, Dmytro, Hong, Seung-Keun, Lloyd, Ricardo V., Park, Jong-In
Publicado 2014

powerTCR: A model-based approach to comparative analysis of the clone size distribution of the T cell receptor repertoire

por Koch, Hillary, Starenki, Dmytro, Cooper, Sara J., Myers, Richard M., Li, Qunhua
Publicado 2018

Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells

por Starenki, Dmytro, Sosonkina, Nadiya, Hong, Seung-Keun, Lloyd, Ricardo V., Park, Jong-In
Publicado 2019

Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells

por Hong, Seung-Keun, Starenki, Dmytro, Johnson, Oleta T., Gestwicki, Jason E., Park, Jong-In
Publicado 2022

Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability

por Wu, Pui-Kei, Hong, Seung-Keun, Starenki, Dmytro, Oshima, Kiyoko, Shao, Hao, Gestwicki, Jason E., Tsai, Susan, Park, Jong-In
Publicado 2020

Transcriptomic Analysis of Canine Osteosarcoma from a Precision Medicine Perspective Reveals Limitations of Differential Gene Expression Studies

por Nance, Rebecca L., Cooper, Sara J., Starenki, Dmytro, Wang, Xu, Matz, Brad, Lindley, Stephanie, Smith, Annette N., Smith, Ashley A., Bergman, Noelle, Sandey, Maninder, Koehler, Jey, Agarwal, Payal, Smith, Bruce F.
Publicado 2022

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer

por Doo, David W., Meza-Perez, Selene, Londoño, Angelina I., Goldsberry, Whitney N., Katre, Ashwini A., Boone, Jonathan D., Moore, Dylana J., Hudson, Cindy T., Betella, Ilaria, McCaw, Tyler R., Gangrade, Abhishek, Bao, Riyue, Luke, Jason J., Yang, Eddy S., Birrer, Michael J., Starenki, Dmytro, Cooper, Sara J., Buchsbaum, Donald J., Norian, Lyse A., Randall, Troy D., Arend, Rebecca C.
Publicado 2020

Obesity diminishes response to PD-1-based immunotherapies in renal cancer

por Boi, Shannon K, Orlandella, Rachael M, Gibson, Justin Tyler, Turbitt, William James, Wald, Gal, Thomas, Lewis, Buchta Rosean, Claire, Norris, Katlyn E, Bing, Megan, Bertrand, Laura, Gross, Brett P, Makkouk, Amani, Starenki, Dmytro, Farag, Kristine I, Sorge, Robert E, Brown, James A, Gordetsky, Jennifer, Yasin, Hesham, Garje, Rohan, Nandagopal, Lakshminarayanan, Weiner, George J, Lubaroff, David M, Arend, Rebecca C, Li, Peng, Zakharia, Yousef, Yang, Eddy, Salem, Aliasger K, Nepple, Kenneth, Marquez-Lago, Tatiana T, Norian, Lyse A
Publicado 2020